What Caught Our Attention in the Investment World? – Week of December 30, 2019 – January 3, 2020

By Kuldip K. Ambastha and Anil K. Ambastha On Friday, January 3, 2020, Tesla, Inc. (TSLA) delivered a gain of 3.0% closing at an all-time high of $443.01 per share due to positive news. Intra-day, the share price reached as high as $454.00 per share. Tesla beat Wall Street estimates for both car production and …

What Caught Our Attention in the Investment World? – Week of December 9-13, 2019

By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …

What Caught Our Attention in the Investment World? – Week of November 18-22, 2019

By Kuldip K. Ambastha and Anil K. Ambastha Karuna Therapeutics Inc. (KRTX), a clinical-stage biopharmaceutical company, was founded in 2009 and is headquartered in Boston, MA. The company is focused on developing innovative therapies for individuals suffering from disabilities, disorders, and pain. Karuna Therapeutics Inc. has announced that its schizophrenia treatment’s Phase 2 clinical trial …

What Caught Our Attention in the Investment World? – Week of October 28-November 1, 2019

By Kuldip K. Ambastha and Anil K. Ambastha On October 28, 2019, New York-based Tiffany & Co.’s stock (TIF) jumped 31.6% for a record one-day gain. The stock surged due to the announcement of a potential $14.5 billion (USD) acquisition bid from LVMH Moët Hennessy (LVMH). LVMH is a Paris-based French company headed by the …

What Caught Our Attention in the Investment World? – Week of October 21-25, 2019

By Kuldip K. Ambastha and Anil K. Ambastha On October 22, 2019, Biogen Inc. (BIIB) delivered a 26.1% return for the day. This was the stock’s largest one-day percentage return in 23 years. Its Alzheimer’s drug (aducanumab) had previously been written off as a failure, but now will be getting a second chance at approval …

What Caught Our Attention in the Investment World? – Week of September 23-27, 2019

By Kuldip K. Ambastha and Anil K. Ambastha BlackBerry Limited (BB) is a prominent Canadian company, previously known as “Research In Motion.” The general public knows BlackBerry Limited best as the developer of the BlackBerry brand of phones and tablets, but in more recent years the company now provides enterprise software and services. From 2001 …

What Caught Our Attention in the Investment World? – Week of September 9-13, 2019

By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …

What Caught Our Attention in the Investment World? – Week of September 3-6, 2019

By Anil K. Ambastha and Kuldip K. Ambastha This past week, the e-signature and electronic document company DocuSign (DOCU) impressed the market with its strong fiscal second-quarter results, improved outlook for the rest of the fiscal year, and addition of 29,000 new customers during the quarter. In return, DocuSign’s stock gained 21.7% on Friday, September …

What Caught Our Attention in the Investment World? – Week of August 26-30, 2019

By Anil K. Ambastha and Kuldip K. Ambastha As the second-quarter earnings reporting period is coming to a close, in this past week the market was not impressed with cosmetic retailer Ulta Beauty (ULTA). The company’s lowered second-half guidance generated multiple analyst downgrades, and the stock dropped by 29.6% on Friday, August 30th, marking its …

What Caught Our Attention in the Investment World? – Week of August 12-16, 2019

By Anil K. Ambastha and Kuldip K. Ambastha Following its disappointing second-quarter earnings due to deep discounting amid rising inventory levels, concern about the potential impact of China tariffs in the future, and slashed earnings guidance for the rest of the year, shares of a retailer, Macy’s (M), dropped by 13.2% on August 14. Macy’s …